Abivax climbs on Lilly takeover speculation
[ad_1] Shares in Abivax were tracking up this morning as a media report in France suggested a takeover by Eli Lilly – worth €15 billion ($17.5 billion) – could be on the cards. French newspaper La Lettre said the Paris-based biotech – which is listed on the Nasdaq – has been on Lilly’s radar after…